All In MedTech

Device Trial Radar · NCT05607771

DaVitri: Semi-Automated Vitrificacion Clinical Study

Paired Non-inferiority Study Comparing Overture Semi-Automated Vitrification System ("DaVitri") to Standard Manual Process

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Suspended

Status

Suspended

Enrollment

72

Planned (sponsor's estimate)

Start

Jul 20, 2023

Primary completion

Nov 30, 2027

Study completion Nov 30, 2027

Sponsor

Lead sponsor
Overture LifeNot on our public-company list
Sponsor type
Industry
First posted
Nov 7, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
Single (participant)
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 30 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main objective of this clinical study is to demonstrate the non-inferiority of the semi automated device (DaVitri) developed by Overture Life in the preparation procedures for vitrification of human samples.

Conditions

  • Fertility Issues

Interventions

  • Manual VitrificationDevice

    Oocytes will be prepared for vitrification using the manual protocol

  • Automated VitrificationDevice

    Oocytes will be prepared for vitrification using the DaVitri device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Thaw survival rates of oocytesTime frame: Day 1

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • WeFIV Buenos Aires

    Buenos Aires, Argentina

  • Halitus Instituto Médico

    Buenos Aires, Argentina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.